LDHC and breast cancer: We found that the stable silencing of LDHC drastically compromised breast cancer cell survival through the accumulation of DNA damage, microtubule destabilization and cell cycle dysregulation, resulting in enhanced cell death, mitotic catastrophe, and senescence.